The Standing Vaccination Commission (Stiko) apparently only wants to recommend the corona vaccine from the US manufacturer Johnson & Johnson for people over 60. A corresponding report by the “Spiegel” coincides with information from NewsABC.net. Younger people should therefore only be allowed to use the vaccine after being informed by a doctor. In response to a request from NewsABC.net, a senior Stiko employee refused to comment.
If it stays that way, it will be a surprising turnaround for the Johnson & Johnson vaccine. Just three weeks ago, NewsABC.net learned from Stiko circles that no age limit was planned for this. At the time, one restriction was mentioned: should the number of cases of cerebral sinus vein thrombosis associated with the vaccine increase, an age restriction could become an issue. It is therefore possible that new information has now changed the mind of the Stiko experts.
German vaccine experts saw a low risk at Johnson & Johnson in April
In the US, Johnson & Johnson’s vaccine was temporarily suspended after eight cases of rare sinus vein thrombosis were found in vaccinated people last month. The cases are spread over 7 million vaccinations. According to the available data, the risk of illness is extremely low. The US health authorities lifted the stop in late April.
The European Medicines Agency (Ema) also declared the Johnson & Johnson vaccine safe after a review in mid-April. According to information from NewsABC.net, experts from the Paul Ehrlich Institute, which is responsible for vaccines in Germany, saw only a very low risk with the vaccine – far lower than, for example, with the vaccine from AstraZeneca. The Johnson & Johnson vaccine also has an advantage over this and other vaccines: it only needs to be vaccinated once to be fully effective.